|
1.
|
2025/01/09
|
|
Genome Analysis of Japanese Yersinia pseudotuberculosis strains Isolated from Kawasaki Disease Patients and other Sources and Their Phylogenetic Positions in the Global Y. pseudotuberculosis Population
|
|
2.
|
2024/12/20
|
|
Clinical Practice Guidelines for the management of Congenital Syphilis in Japan, 2023: Executive Summary
|
|
3.
|
2024/05/08
|
|
Lauunch of Board Certification in Pediatric Infectious Diseases in Japan
|
|
4.
|
2023/03/01
|
|
Acute and Postacute Clinical Characteristics of Coronavirus Disease 2019 in Children in Japan
|
|
5.
|
2022/05/16
|
|
Clinical evaluation of a new rapid immunochromatographic test for detection of Bordetella pertussis antigen
|
|
6.
|
2022/05/12
|
|
Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021
|
|
7.
|
2022/04
|
|
Introduction of the Japanese Society for Pediatric Infectious Diseases
|
|
8.
|
2022/03/17
|
|
Recent Trends in the Epidemiology, Diagnosis, and Treatment of Macrolide-Resistant Mycoplasma pneumoniae
|
|
9.
|
2022/01
|
|
The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan
|
|
10.
|
2021/09/29
|
|
Global Pediatric Pulmonology Alliance (GPPA) proposal for COVID-19 vaccination in children
|
|
11.
|
2020/12
|
|
bronchitis, bronchiolitis
|
|
12.
|
2020/11
|
|
Low prevalence of Chlamydia pneumoniae infections during the Mycoplasma pneumoniae epidemic season: Results of nationwide surveillance in Japan
|
|
13.
|
2020/06/25
|
|
A Case of Adrenoleukodystrophy Diagnosed Based on Visual Disturbance
|
|
14.
|
2019/11/18
|
|
A Study of Gram Stained Specimens Obtained from Pediatric Inpatients of Kawasaki Medical School Hospital - Achievements from an elementary research experiment by a 2nd year medical student.
|
|
15.
|
2019/11
|
|
Multi-season analyses of causative pathogens in children hospitalized with asthma exacerbation.
|
|
16.
|
2019/10/21
|
|
Novel USP9X variants in two patients with X-linked intellectual disability.
|
|
17.
|
2019/10
|
|
Correction to:Investigation of novel variations of ORAI1 gene and their association with Kawasaki disease.
|
|
18.
|
2019/10
|
|
Regulatory aspects of quality and safety for live recombinant viral vaccines against infectious diseases in Japan
|
|
19.
|
2019/09
|
|
A case of acute encephalophathy with residual neurological sequelae induced by immunoglobulin A vasculitis.
|
|
20.
|
2019/07
|
|
Comparing Antimicrobial Susceptibilities among Mycoplasma pneumoniae Isolates from Pediatric Patients in Japan between Two Recent Epidemic Periods
|
|
21.
|
2019/06
|
|
Investigation of novel variations of ORAI1 gene and their association with Kawasaki disease.
|
|
22.
|
2019/06
|
|
The diagnostic accuracy of biomarkers for the prediction of bacteremia in patients with suspected infection: a prospective observational study
|
|
23.
|
2019/05/07
|
|
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial
|
|
24.
|
2019/05
|
|
Identification of the Causative Microorganism of Suspected Bacterial Meningitis by Exhaustive Analysis of the 16S rRNA Sequence - Achievements from a research experiment course by a 3rd year medical student -
|
|
25.
|
2019/03
|
|
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA):a randomised controlled, open-label, blinded-endpoints, phase 3 trial.
|
|
26.
|
2019/02
|
|
LAMP-based assay can rectify the diagnosis of Yersinia pseudotuberculosis infections otherwise missed by serology
|
|
27.
|
2019/01
|
|
Novel neuroblastoma amplified sequence (NBAS) mutations in a Japanese boy with fever-triggered recurrent acute liver failure.
|
|
28.
|
2018/11
|
|
A Safety and Immunogenicity Study of a Single Dose of a Meningococcal (Groups A, C, W, and Y) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (MEN-ACWY-D) in Healthy Japanese Participants.
|
|
29.
|
2018/11
|
|
Incidence of Viremia With DNA Viruses in Oncology Patients With Febrile Neutropenia
|
|
30.
|
2018/03
|
|
Acute rheumatic fever associated with tenosynovitis and a unique cytokine profile
|
|
31.
|
2017/11
|
|
Changes of Antibody Associated with Cell-Mediated Immunity in College Students During Two Years after Rubella Vaccination
|
|
32.
|
2017/10
|
|
Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015
|
|
33.
|
2017/08
|
|
Cellular and humoral immunity after vaccination or natural mumps infection
|
|
34.
|
2017/07
|
|
Changes in rotavirus genotypes before and after vaccine introduction: a multicenter, prospective observational study in three areas of Japan
|
|
35.
|
2017/05
|
|
Histological findings in severe Mycoplasma pneumoniae pneumonia.
|
|
36.
|
2017/05
|
|
Pediatric community-acquired pneumonia treated with a three-day course of tebipenem pivoxil.
|
|
37.
|
2017/01
|
|
A case of sitosterolemia due to compound heterozygous mutations in ABCG5: clinical features and treatment outcomes obtained with colestimide and ezetimibe
|
|
38.
|
2016/10
|
|
Predictive values of egg-specific IgE by two commonly used assay systems for the diagnosis of egg allergy in young children: a prospective multicenter study.
|
|
39.
|
2016/08
|
|
Numerous intertriginous xanthomas in infant: A diagnostic clue for sitosterolemia
|
|
40.
|
2016/07
|
|
JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy - The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG.
|
|
41.
|
2016/05
|
|
Rapid diagnostic method for the identification of Mycoplasma pneumoniae respiratory tract infection
|
|
42.
|
2016/03
|
|
Macrolide Therapy for Prevention of Exacerbation in Individuals with Diffuse Aspiration Bronchiolitis
|
|
43.
|
2016/01
|
|
Variations in ORAI1 Gene Associated with Kawasaki Disease
|
|
44.
|
2015/12
|
|
Chlamydia pneumoniae CPj0783 interaction with Huntingtin-protein14
|
|
45.
|
2015/11
|
|
A Japanese study to assess immunogenicity and safety of a typhoid Vi polysaccharide vaccine
|
|
46.
|
2015/11
|
|
Rubella specific cell-mediated and humoral immunity following vaccination in college students with low antibody titers
|
|
47.
|
2015/07
|
|
Antibody responses of Chlamydophila pneumoniae pneumonia: Why is the diagnosis of C. pneumoniae pneumonia difficult?
|
|
48.
|
2015/07
|
|
Detection failure rate of chest radiography for the identification of nursing and healthcare-associated pneumonia
|
|
49.
|
2015/06
|
|
Diagnostic sensitivity of a rapid antigen test for the detection of Mycoplasma pneumoniae: Comparison with real-time PCR
|
|
50.
|
2015/03
|
|
Detection of bacteria and fungi in blood of patients with febrile neutropenia by real-time PCR with universal primers and probes
|
|
51.
|
2015/03
|
|
Setting a standard for the initiation of steroid therapy in refractory or severe Mycoplasma pneumoniae pneumonia in adolescents and adults
|
|
52.
|
2015/02
|
|
Varicella-zoster virus-specific, cell-mediated immunity with interferon-gamma release assay after vaccination of college students with no or intermediate IgG antibody response
|
|
53.
|
2014/12
|
|
Sulfamethoxazole / Trimethoprim confer no change on the clinical course of Kawasaki disease
|
|
54.
|
2014/11
|
|
Kawasaki disease-specific molecules in the sera are linked to microbe-associated molecular patterns in the biofilms.
|
|
55.
|
2014/04
|
|
Detection of Bacteria, Fungi, and Viruses by a Real-time PCR assay using universal primers and probes from Blood in Patients with Febrile Neutropenia
|
|
56.
|
2014/04
|
|
Management of refractory Mycoplasma pneumoniae pneumonia: Utility of measuring serum lactate dehydrogenase level
|
|
57.
|
2014/04
|
|
The exacerbation risk prediction by fractional exhaled nitric oxide in younger and elder children with bronchial asthma
|
|
58.
|
2014/01
|
|
Chest computed tomography for the diagnosis of Mycoplasma pneumoniae infection
|
|
59.
|
2013/12
|
|
Atelectasis caused by macrolide-resistant Mycoplasma pneumoniae pneumonia in an adult patient
|
|
60.
|
2013/12
|
|
Transmission of macrolide-resistant Mycoplasma pneumoniae within a family
|
|
61.
|
2013/10
|
|
Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility, and therapeutic efficacy
|
|
62.
|
2013/09
|
|
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in healthy infants in Japan
|
|
63.
|
2013/08
|
|
Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients
|
|
64.
|
2013/06
|
|
Nationwide survey of the development of drug resistance in the pediatric field in 2007 and 2010: drug sensitivity of Haemophilus influenzae in Japan (second report)
|
|
65.
|
2013/05
|
|
Therapeutic Efficacy of Macrolides, Minocycline, and Tosufloxacin against Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Pediatric Patients
|
|
66.
|
2013/04
|
|
Chlamydophila pneumoniae serology:cross-reaction with Mycoplasma pneumoniae infection
|
|
67.
|
2013/04
|
|
Evaluation of serological tests for diagnosis of Chlamydophila pneumoniae pneumonia in patients with nursing and healthcare-associated pneumonia
|
|
68.
|
2013/03
|
|
Atelectasis caused by macrolide-resistant Mycoplasma pneumoniae pneumonia in an adult patient.
|
|
69.
|
2013/03
|
|
Atelectasis caused by macrolide-resistant Mycoplasma pneumoniae pneumonia in an adult patient
|
|
70.
|
2013/03
|
|
Diagnostic value of symptoms and laboratory data for pertussis in adolescent and adult patients
|
|
71.
|
2013/03
|
|
Diagnostic value of symptoms and laboratory data for pertussis in adolescent and adult patients.
|
|
72.
|
2013/01
|
|
Recent trends on vaccine preventable bacterial and viral infections in Japan
|
|
73.
|
2012/12
|
|
Ehlers-Danlos syndrome, vascular type: A novel missense mutation in the COL3A1 gene.
|
|
74.
|
2012/11
|
|
In vitro activities of 11 antimicrobial agents against macrolide-resistant Mycoplasma pneumoniae isolates from pediatric patients: results from a multicenter surveillance study
|
|
75.
|
2012/10
|
|
A case of meningoencephalitis associated with macrolide-resistant Mycoplasma pneumoniae infection
|
|
76.
|
2012/10
|
|
Chlamydophila pneumoniae serology: cross-reaction with Mycoplasma pneumoniae infection.
|
|
77.
|
2012/10
|
|
Evaluation of serological tests for diagnosis of Chlamydophila pneumoniae pneumonia in patients with nursing and healthcare-associated pneumonia.
|
|
78.
|
2012/10
|
|
Influence of age on the clinical differentiation of atypical pneumonia in adults.
|
|
79.
|
2012/05
|
|
A genome-wide association study identifies three new risk loci for Kawasaki disease
|
|
80.
|
2012/05
|
|
Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia.
|
|
81.
|
2012/04
|
|
Genomic screening for Chlamydophila pneumoniae-specific antigens using serum samples from patients with primary infection.
|
|
82.
|
2012/03
|
|
Clinical features and the role of atypical pathogens in nursing and healthcare-associated pneumonia (NHCAP): differences between teaching university hospital and community hospital.
|
|
83.
|
2012/02
|
|
Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients
|
|
84.
|
2011/11
|
|
Evaluation of serological tests for diagnosis of Bordetella pertussis infection in adolescents and adults
|
|
85.
|
2011/07
|
|
Guidelines for Diagnosis and Treatment of Anaerobic Infections
|
|
86.
|
2011/05
|
|
Japanese Guidelines for the Management of Respiratory Infectious Diseases in Children 2007 with focus on pneumonia
|
|
87.
|
2011/04
|
|
Natural alteration of antibody titers in a patient with immunoglobulin A deficiency after chickenpox over a 10-year period
|
|
88.
|
2011/04
|
|
Outbreak of pertussis in a university laboratory
|
|
89.
|
2011/04
|
|
Outbreak of pertussis in a university laboratory.
|
|
90.
|
2011/03
|
|
Clinical potential of diagnostic methods for the rapid diagnosis of Mycoplasma pneumoniae pneumonia in adults.
|
|
91.
|
2011/02
|
|
Community-acquired macrolide-resistant Mycoplasma pneumoniae pneumonia in patients more than 18 years of age.
|
|
92.
|
2011/02
|
|
High serum arginase I levels in asthma: its correlation with high-sensitivity C-reactive protein.
|
|
93.
|
2011
|
|
A case report of measles in a premature infant and the antibody and/or the virus RNA in the patients contracted in infancy
|
|
94.
|
2010/12
|
|
Results of a multicenter survey of diagnosis and treatment for bacterial
meningitis in Japan.
|
|
95.
|
2010/10
|
|
Macrolide-resistant Mycoplasma pneumoniae in adults with community-acquired pneumonia.
|
|
96.
|
2010/07
|
|
Common variants in CASP3 confer susceptibility to Kawasaki disease.
|
|
97.
|
2010/03
|
|
Evaluation of false-positive reaction with ELISA for the detection of Chlamydophila pneumoniae-specific IgM antibody in adults.
|
|
98.
|
2009/10
|
|
Development of a novel functional high-throughput screening system for pathogen effectors in the yeast Saccharomyces cerevisiae.
|
|
99.
|
2009/07
|
|
Assay of Chlamydia pneumoniae-Specific IgM Antibodies by ELISA Method-Reduction of Non-Specific Reaction and Resetting of Serological Criteria by Measuring IgM Antibodies-
|
|
100.
|
2009/07
|
|
Development and evaluation of a loop-mediated isothermal amplification method for the rapid detection of Chlamydophila pneumoniae.
|
|
101.
|
2009/04
|
|
Radiographic features of Mycoplasma pneumoniae pneumonia: differential diagnosis and performance timing.
|
|
102.
|
2009/04
|
|
The effect of inhaled corticosteroids on Chlamydophila pneumoniae and Mycoplasma pneumoniae infection in children with bronchial asthma.
|
|
103.
|
2008/08
|
|
Mycoplasma pneumoniae pneumonia in the elderly.
|
|
104.
|
2008/06
|
|
Rapid and simple diagnosis of Chlamydophila pneumoniae pneumonia by an immunochromatographic test for detection of immunoglobulin M antibodies.
|
|
105.
|
2008/05
|
|
Comparison of serological tests for detection of immunoglobulin M antibodies to Chlamydophila pneumoniae.
|
|
106.
|
2008/04
|
|
Assessment of the usefulness of sputum Gram stain and culture for diagnosis of community-acquired pneumonia requiring hospitalization.
|
|
107.
|
2008/03
|
|
Evaluation of enzyme-linked immunosorbent assay for Chlamydophila pneumoniae-specific immunoglobulin M in acute respiratory tract infection.
|
|
108.
|
2008/01
|
|
Adolescent jump case in Japan associated with influenza but not oseltamivir
|
|
109.
|
2008/01
|
|
ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms.
|
|
110.
|
2008
|
|
An Infant Case of Neutropenia Developed Repeated Omphalitis:A Case Report
|
|
111.
|
2008
|
|
Localized Intra-Abdominal Kikuchi-Fujimoto Disease:a case Report and Review of the Literature
|
|
112.
|
2008
|
|
Macrolide-resistant Mycoplasma pneumoniae in patients with community-acquired pneumonia.
|
|
113.
|
2007/12
|
|
Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit.
|
|
114.
|
2007/06
|
|
Evaluation of the diagnostic usefulness of real-time PCR for detection of Chlamydophila pneumoniae in acute respiratory infections.
|
|
115.
|
2006/11
|
|
Outbreak of Chlamydia pneumoniae infection in a Japanese nursing home, 1999-2000.
|
|
116.
|
2006/11
|
|
Sivelestat relieves respiratory distress refractory to dexamethasone in all-trans retinoic acid syndrome: a report of two cases.
|
|
117.
|
2006/08
|
|
Factor XIII in Henoch-Schonlein purpura with isolated gastrointestinal symptoms
|
|
118.
|
2006/03
|
|
Absence of Chlamydia psittaci in ocular adnexal lymphoma from Japanese patients.
|
|
119.
|
2006/02
|
|
The inhibitory effect of antihyperlipidemic drugs on the growth of Chlamydia pneumoniae in vitro.
|
|
120.
|
2006
|
|
Evaluation of serological tests detecting Chlamydophila pneumoniae-specific immunoglobulin M antibody
|
|
121.
|
2005/12
|
|
A Case of Mediastinal T-cell Lymphoblastic Lymphoma Causing Superior Mediastinal Syndrome and Severe Complications
|
|
122.
|
2005/06
|
|
Biosynthesized tea polyphenols inactivate Chlamydia trachomatis in vitro.
|
|
123.
|
2005/06
|
|
In vitro inhibitory effects of hinokitiol on proliferation of Chlamydia trachomatis.
|
|
124.
|
2005/02
|
|
Chlamydia pneumoniae infection as a risk factor for subarachnoid hemorrhage.
|
|
125.
|
2005/01
|
|
Prevalence of antibodies against Simkania negevensis in a healthy Japanese population determined by the microimmunofluorescence test.
|
|
126.
|
2005
|
|
Outbreak of infection in long-term care facilities and an affiliated hospital.
|
|
127.
|
2004/12
|
|
CD40 ligand gene and Kawasaki disease.
|
|
128.
|
2004/12
|
|
Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan.
|
|
129.
|
2004/02
|
|
Factors improving the propagation of Simkania negevensis strain Z in cell culture.
|
|
130.
|
2003/05
|
|
Aspirin inhibits Chlamydia pneumoniae-induced NF-kappa B activation, cyclo-oxygenase-2 expression and prostaglandin E2 synthesis and attenuates chlamydial growth.
|
|
131.
|
2003/01
|
|
Polymorphism of SLC11A1 (formerly NRAMP1) gene confers susceptibility to Kawasaki disease.
|
|
Display 5 items
|
|
Display all(131)
|
